Olmesartan Medoxomil and Rosuvastatin Tablets 20/5 mg
Olmesartan Medoxomil 20mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
MFDS item code 202003945 · Approved 2020.05.28
This product's status changed to Expired on 2025.05.28. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of hypertension; improvement of dyslipidemia; suppression of atherosclerosis progression and cardiovascular risk
This medication is used for patients who require combined therapy with olmesartan medoxomil for the treatment of essential hypertension and rosuvastatin, which is effective for hypercholesterolemia and various lipid disorders. Olmesartan medoxomil helps to control hypertension and improve vascular health. Rosuvastatin is used in the treatment of hypercholesterolemia and mixed dyslipidemia, and is utilized as an adjunct when dietary management or exercise is insufficient. Additionally, it helps to delay the progression of arteriosclerosis due to hypercholesterolemia and reduce cardiovascular disease risk, aiding in the prevention of stroke, myocardial infarction, and risks following revascularization procedures. Using these two medications together effectively treats hypertension and dyslipidemia.
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, olmesartan medoxomil/rosuvastatin. ◆ Olmesartan medoxomil 1. Adults The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase the dose to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg daily. To improve adherence, it is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). In patients who may have intravascular volume depletion (e.g., patients taking diuretics, especially those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. 2. Elderly patients No dose adjustment is necessary when this medicine is administered to patients aged 65 years or older. 3. Patients with renal impairment The maximum dose in patients with mild to moderate renal impairment (creatinine clearance 30-60mL/min) is 20mg once daily. 4. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment. The recommended initial dose in patients with moderate hepatic impairment is 10mg once daily, and the dose may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended. ◆ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; if a greater reduction in LDL-cholesterol is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, and most patients are controlled at this dose. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or more according to LDL-cholesterol levels, the treatment goal, and the patient's response, and may be increased to a maximum of 20 milligrams daily. 2. Elderly patients No dose adjustment is necessary. 3. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering this medicine at 20mg to patients with moderate renal impairment. 5. Race Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients. Patients taking olmesartan medoxomil and rosuvastatin concomitantly may switch to this medicine (a fixed-dose combination containing the same amounts of each active ingredient) for convenience of administration.
The safety and efficacy in children under 18 years of age have not been established.
This medication can cause serious harm or death to the fetus and newborn if taken during the second or third trimester of pregnancy, so it must be discontinued immediately if pregnancy is confirmed. Patients who are hypersensitive to this medication, pregnant, or potentially pregnant women, and nursing mothers should not take it, especially fertile women not using appropriate contraception should be cautious. Do not administer it to patients with severely impaired kidney function or those undergoing dialysis, severe liver disease, bile duct obstruction, and certain muscle disorders. This medication contains lactose and should not be taken by patients with lactose intolerance or related genetic disorders. Patients with decreased blood volume or low sodium levels may experience hypotensive symptoms when starting this medication, so their condition should be closely monitored. Patients with impaired kidney function or those who have undergone kidney transplantation should have their potassium and creatinine levels checked regularly. Due to the risk of hyperkalemia, serum potassium levels should be frequently monitored, and special caution should be taken with cardiovascular disease patients or those with specific heart valve diseases while taking this medication. Muscle pain or myopathy may occur, and in rare cases, rhabdomyolysis may occur, so any unusual muscle symptoms should be reported to healthcare personnel immediately. Patients with a history of excessive alcohol intake or liver disease should have regular liver function tests and use this medication with caution. Dizziness or drowsiness may occur, so caution is needed when driving or operating dangerous machinery. This medication may interact with other specific drugs, so it is essential to consult with healthcare personnel if you are taking any other medications. Pregnant and nursing women should avoid taking this medication, and women who might become pregnant should use appropriate contraception. Safety has not been established for children and adolescents under 18 years old, so its use is not recommended. Elderly patients may have higher drug concentrations in their bodies, so monitoring of dosage and condition is necessary. In case of overdose, symptoms such as hypotension or cardiac arrhythmias may occur; thus, immediate medical assistance is required, and specific antidotes are not available, so symptomatic treatment is important. This medication should be kept out of reach of children, and transferring it to another container may affect its quality.
Increased ALT, increased AST, elevated blood creatinine, decreased creatinine clearance, headache, dizziness, sensory impairment, neuromyopathy, drowsiness, gastroesophageal reflux, constipation, dental caries, dyspepsia, gastric ulcer, gastritis, gastroenteritis, musculoskeletal stiffness, atrial fibrillation, hypoglycemia, chest pain, tooth extraction, thoracic pain, peripheral edema, vertigo, abdominal pain, nausea, palpitations, hypercholesterolemia, hyperlipidemia, hyperuricemia, arthralgia, arthritis, myalgia, rash, weakness, angioedema, anaphylactic reaction, vomiting, chronic malabsorption syndrome, rhabdomyolysis, hyperkalemia, acute renal failure, hair loss, pruritus, urticaria, autoimmune hepatitis, dizziness (including positional dizziness), palpitations, increased blood pressure, facial edema, low back pain, increased blood creatinine, diarrhea, cough, epistaxis, upper respiratory tract infection, asthma, hypersensitivity reaction including angioedema, diabetes, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, shortness of breath, diarrhea, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal hepatic failure, cognitive impairment, severe muscular weakness, ocular myasthenia
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture from entering. It is recommended to maintain storage temperatures between 1 degree to 30 degrees Celsius. This way, the medication's efficacy can be safely preserved.
White or yellowish circular film-coated tablets
30 tablets/box [30 tablets (10 tablets/Alu-Alu) × 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olmesartan Medoxomil 20mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 10mg
Tablet · Prescription medication · Combination
(Co., Ltd. Daewoong Pharmaceutical)
CombinationRosuvastatin Calcium 5.2mg · Olmesartan Medoxomil 10mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Daewoong Pharmaceutical
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.